================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

        Date of report (Date of earliest event reported) October 27, 2005

                          VARIAN MEDICAL SYSTEMS, INC.
             ------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)

            Delaware                     1-7598                94-2359345
  ----------------------------      ----------------       -------------------
  (State or Other Jurisdiction      (Commission File          (IRS Employer
       of Incorporation)                Number)            Identification No.)

            3100 Hansen Way, Palo Alto, CA                    94304-1030
       ----------------------------------------               -----------
       (Address of Principal Executive Offices)               (Zip Code)

        Registrant's telephone number, including area code (650) 493-4000

                                 Not Applicable
          -------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ]  Written communications pursuant to Rule 425 under the Securities
     Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange
     Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

================================================================================



Item 7.01.  Regulation FD Disclosure.

         On August 26, 2005, Varian Medical Systems, Inc. (the "Company")
conducted an earnings conference call regarding the Company's financial results
for the fourth quarter of fiscal year 2005 and for the full year of fiscal year
2005 and issued a press release regarding such financial results. Certain
persons may not have been available to participate in the full earnings
conference call due to technical difficulties experienced during the conference
call. As previously announced in the Company's press release, a replay of the
call can be accessed through the investor relations page on the Company's web
site at www.varian.com where it will be archived for a year. A replay can also
be accessed by dialing 1-888-286-8010 from inside the U.S or 1-617-801-6888 from
outside the U.S. and entering confirmation code 45760068. The telephone replay
will be available through 5 p.m. PT, October 28, 2005.



                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                           Varian Medical Systems, Inc.

                                           By:    /s/ JOHN W. KUO
                                                  ------------------------------
                                           Name:  John W. Kuo
                                           Title: Corporate Vice President,
                                                  General Counsel and Secretary

Dated: October 27, 2005